收费全文 | 2223篇 |
免费 | 133篇 |
国内免费 | 5篇 |
耳鼻咽喉 | 38篇 |
儿科学 | 195篇 |
妇产科学 | 58篇 |
基础医学 | 275篇 |
口腔科学 | 70篇 |
临床医学 | 171篇 |
内科学 | 408篇 |
皮肤病学 | 51篇 |
神经病学 | 114篇 |
特种医学 | 50篇 |
外科学 | 304篇 |
综合类 | 46篇 |
一般理论 | 5篇 |
预防医学 | 149篇 |
眼科学 | 52篇 |
药学 | 149篇 |
中国医学 | 19篇 |
肿瘤学 | 207篇 |
2024年 | 4篇 |
2023年 | 19篇 |
2022年 | 27篇 |
2021年 | 76篇 |
2020年 | 39篇 |
2019年 | 67篇 |
2018年 | 78篇 |
2017年 | 67篇 |
2016年 | 73篇 |
2015年 | 52篇 |
2014年 | 77篇 |
2013年 | 108篇 |
2012年 | 166篇 |
2011年 | 197篇 |
2010年 | 80篇 |
2009年 | 74篇 |
2008年 | 143篇 |
2007年 | 131篇 |
2006年 | 124篇 |
2005年 | 87篇 |
2004年 | 99篇 |
2003年 | 107篇 |
2002年 | 95篇 |
2001年 | 35篇 |
2000年 | 35篇 |
1999年 | 41篇 |
1998年 | 20篇 |
1997年 | 13篇 |
1996年 | 11篇 |
1995年 | 7篇 |
1994年 | 8篇 |
1993年 | 12篇 |
1992年 | 17篇 |
1991年 | 16篇 |
1990年 | 8篇 |
1989年 | 12篇 |
1988年 | 14篇 |
1987年 | 17篇 |
1986年 | 12篇 |
1985年 | 13篇 |
1984年 | 10篇 |
1983年 | 6篇 |
1982年 | 10篇 |
1981年 | 7篇 |
1980年 | 6篇 |
1979年 | 9篇 |
1978年 | 7篇 |
1977年 | 4篇 |
1973年 | 4篇 |
1971年 | 4篇 |
Background
The inclusion of hepatitis B core antibody-positive (HBcAb+) liver donors is a strategy utilized to increase organ availability. This study examined HBcAb+ transplantation practices to identify specific factors influencing outcomes.Methods
Twenty-five HBcAb+ liver transplants were identified retrospectively among 868 adult transplants performed between 1 January 1997 and 31 December 2009. Twelve (48%) recipients had hepatitis C and five (20%) had hepatitis B. Patient and donor demographics, preoperative morbidity, transplant data and outcomes were examined. Statistical analysis was completed using Student''s t-test or the Kaplan–Meier method. A P-value of <0.05 was considered significant.Results
There was no difference in age, body mass index or comorbidities between HBcAb+ liver recipients and control subjects. Model for End-stage Liver Disease (MELD) scores of >30 were significantly more frequent in HBcAb+ liver recipients (32% vs. 15%; P = 0.04). All patients received immunoglobulin and longterm antiviral therapy as prophylaxis against graft hepatitis B resurgence. No patients who received HBcAb+ livers developed hepatitis B infection on follow-up. Overall survival at 30 days, 1 year and 5 years in HBcAb+ liver recipients was 92%, 74% and 74%, respectively, compared with 96%, 89% and 76%, respectively, in the control group (P = not significant, log-rank test). All except one of the deaths in the HBcAb+ liver recipient group occurred within 90 days postoperatively and in patients with MELD scores >30.Conclusions
The practice of transplanting HBcAb+ grafts incurs low risk for infection using current methods of prophylaxis. The highest mortality risk was in the early postoperative period, specifically in patients with very high MELD scores. This probably reflects the practice of using positive serology grafts in emergent situations. 相似文献To describe the demographics, clinical features, and treatment outcomes with systemic steroids in eyes presenting with post-fever retinitis (PFR) from Central India.
MethodsSingle-center, retrospective analysis of 147 eyes of 98 PFR cases between 2011 and 2019.
ResultsMean age of the study cohort was 33.46?±?12.76 years, with 72 males and 26 females. The mean interval between the onset of fever and the diminution of vision was 21.10?±?13.54 days (range 0–60 days). The number of PFR cases increased over the nine years with 89 cases (90.1%) presenting during winters. Unilateral involvement was seen in 49 cases, while 49 had bilateral involvement. Clinical characteristics included: multifocal retinitis (n?=?122; 61.2%), hemorrhages (n?=?132; 89.8%), disc edema (n?=?57; 38.8%), anterior chamber reaction (n?=?28; 19%), and vitritis (n?=?103; 70.1%). Treatment included intravenous followed by oral steroids in 70 patients and oral steroids exclusively in 23; five patients denied treatment. The visual acuity improved from 1.09?±?0.52 LogMAR to 0.29?±?0.42 LogMAR (p?<?0.05).
ConclusionThere has been an increase in the prevalence of PFR cases over the last decade with clustering during the winters. Multifocal retinitis, retinal hemorrhages, and vitritis were the most common clinical findings in our series. The retinitis resolved with improvement in vision following steroid therapy in all eyes.
相似文献Background
Idiopathic steroid-resistant nephrotic syndrome (SRNS) has been associated with the presence of a circulating focal sclerosis permeability factor (FSPF) thought to damage the glomerular barrier and increase permeability to albumin. Galactose binds and inactivates FSPF in vitro, but its effect in vivo is uncertain.Methods
A prospective clinical trial was conducted to investigate the effect of oral galactose on FSPF and proteinuria in children with SRNS. Seven pediatric subjects with idiopathic SRNS and positive FSPF activity (>0.5) were treated with oral galactose (0.2 gm/kg/dose twice daily) for 16 weeks. Post-treatment FSPF and proteinuria were measured.Results
Focal sclerosis permeability factor activity of the seven subjects decreased from 0.69?±?0.11 to 0.35?±?0.21 (p?=?0.009) in response to galactose. The two subjects with post-transplant recurrence of focal segmental glomerulosclerosis (FSGS) demonstrated the most significant improvement in FSPF (p?=?0.006). Despite this decrease in FSPF, the pre- and post-treatment urine protein:creatinine ratio remained unchanged and no subject achieved remission.Conclusions
Galactose decreases FSPF in children with SRNS, with the most significant improvement in those with post-transplant FSGS recurrence, but it fails to improve proteinuria. At the present time there is no evidence to support the use of galactose in children with FSGS, either pre- or post-transplant. Future studies to investigate the role of galactose as preemptive therapy to decrease the risk of post-transplant FSGS recurrence may be useful. 相似文献![点击此处可从《Head & neck》网站下载免费的PDF全文](/ch/ext_images/free.gif)